As EMP2 expression can be heterogeneous within the naïve tumor parenchyma, it is possible that strongly EMP2-positive cells are more resistant to taxane treatment, thus leaving the tumor mostly populated with “high-EMP2” cells after taxane treatment. Here, EMP2 is linked to neoplasm.